Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials!!

Clinical Trial 9239

New York, NY 10003

Study Summary:

A double-blind, vehicle-controlled, randomized, parallel design, multiple-site clinical study to evaluate the efficacy and safety of desoximetasone 0.25% topical spray in patients with moderate to severe plaque psoriasis.

The objective of this study is to demonstrate that desoximetasone 0.25% topical spray is effective for the treatment of patients with moderate to severe plaque psoriasis.

Qualified Participants Must:

• Be a male or non-pregnant, non-lactating female, 18 years of age or older
• Have a definite clinical diagnosis of stable plaque psoriasis involving ≥ 10% of the body surface area (BSA)
• Have a combined total lesion severity score (TLSS) of ≥ 7 for the Target Lesion
• Have a plaque elevation score ≥ 3 of (moderate) for the Target Lesion
• The Target Lesion must have an area of at least 5 cm²
• Have a Physicians Global Assessment (PGA) score of 3 (moderate) or 4 (severe) at baseline for the overall disease severity

Qualified Participants May Receive:

Free medical services once a week for a month and $25 per visit.

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.